<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.0 20040830//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">09-PONE-RA-12190R1</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0007523</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Biochemistry/Cell Signaling and Trafficking Structures</subject><subject>Cell Biology/Cell Signaling</subject><subject>Cell Biology/Cellular Death and Stress Responses</subject></subj-group></article-categories><title-group><article-title>Akt1 Intramitochondrial Cycling Is a Crucial Step in the Redox Modulation of Cell Cycle Progression</article-title><alt-title alt-title-type="running-head">Redox Mitochondrial Akt1</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Antico Arciuch</surname><given-names>Valeria Gabriela</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Galli</surname><given-names>Soledad</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Franco</surname><given-names>Mar&#x000ed;a Clara</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lam</surname><given-names>Philip Y.</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cadenas</surname><given-names>Enrique</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Carreras</surname><given-names>Mar&#x000ed;a Cecilia</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Poderoso</surname><given-names>Juan Jos&#x000e9;</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Laboratory of Oxygen Metabolism, University Hospital, University of Buenos Aires, Buenos Aires, Argentina</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Department of Organic Chemistry, Faculty of Exact and Natural Sciences, University of Buenos Aires, Buenos Aires, Argentina</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Laboratory of Motor Neuron Biology, Burke Medical Research Institute, University of Cornell, New York, New York, United States of America</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, California, United States of America</addr-line></aff><aff id="aff5"><label>5</label><addr-line>Department of Clinical Biochemistry, University Hospital, School of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>White</surname><given-names>Anthony Robert</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">University of Melbourne, Australia</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>vantico@hospitaldeclinicas.uba.ar</email> (VGAA); <email>jpoderos@fmed.uba.ar</email> (JJP)</corresp><fn fn-type="con"><p>Conceived and designed the experiments: VGAA MCC JJP. Performed the experiments: VGAA SG MCF PL. Analyzed the data: VGAA EC MCC JJP. Contributed reagents/materials/analysis tools: EC. Wrote the paper: VGAA JJP.</p></fn></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>21</day><month>10</month><year>2009</year></pub-date><volume>4</volume><issue>10</issue><elocation-id>e7523</elocation-id><history><date date-type="received"><day>10</day><month>8</month><year>2009</year></date><date date-type="accepted"><day>29</day><month>9</month><year>2009</year></date></history><permissions><copyright-statement>Antico Arciuch et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement></permissions><abstract><p>Akt is a serine/threonine kinase involved in cell proliferation, apoptosis, and glucose metabolism. Akt is differentially activated by growth factors and oxidative stress by sequential phosphorylation of Ser<sup>473</sup> by mTORC2 and Thr<sup>308</sup> by PDK1. On these bases, we investigated the mechanistic connection of H<sub>2</sub>O<sub>2</sub> yield, mitochondrial activation of Akt1 and cell cycle progression in NIH/3T3 cell line with confocal microscopy, <italic>in vivo</italic> imaging, and directed mutagenesis. We demonstrate that modulation by H<sub>2</sub>O<sub>2</sub> entails the entrance of cytosolic P-Akt1 Ser<sup>473</sup> to mitochondria, where it is further phosphorylated at Thr<sup>308</sup> by constitutive PDK1. Phosphorylation of Thr<sup>308</sup> in mitochondria determines Akt1 passage to nuclei and triggers genomic post-translational mechanisms for cell proliferation. At high H<sub>2</sub>O<sub>2</sub>, Akt1-PDK1 association is disrupted and P-Akt1 Ser<sup>473</sup> accumulates in mitochondria in detriment to nuclear translocation; accordingly, Akt1 T308A is retained in mitochondria. Low Akt1 activity increases cytochrome <italic>c</italic> release to cytosol leading to apoptosis. As assessed by mass spectra, differential H<sub>2</sub>O<sub>2</sub> effects on Akt1-PDK interaction depend on the selective oxidation of Cys<sup>310</sup> to sulfenic or cysteic acids. These results indicate that Akt1 intramitochondrial-cycling is central for redox modulation of cell fate.</p></abstract><counts><page-count count="13"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Akt (formerly protein kinase B) is a serine/threonine kinase implicated in the regulation of cell cycle progression, cell death, adhesion, migration, metabolism and tumorigenesis <xref ref-type="bibr" rid="pone.0007523-Brazil1">&#x0005b;1&#x0005d;</xref>. In 1991, collaborative studies resulted in the cloning of the viral oncogene <italic>v</italic>-akt. The predicted oncoprotein contained viral Gag sequences fused to a kinase related to protein kinase C <xref ref-type="bibr" rid="pone.0007523-Bellacosa1">&#x0005b;2&#x0005d;</xref>. Akt possesses an N-terminal pleckstrin homology (PH) domain (residues 1&#x02013;113), a kinase domain (residues 150&#x02013;408) that is similar to those found in other AGC members, such as cAMP-dependent protein kinase and protein kinase C, and a C-terminal regulatory domain (residues 409&#x02013;480) containing a hydrophobic motif <xref ref-type="bibr" rid="pone.0007523-Bellacosa1">&#x0005b;2&#x0005d;</xref>. Akt defines a family of closely related, highly conserved cellular homologues <xref ref-type="bibr" rid="pone.0007523-Staal1">&#x0005b;3&#x0005d;</xref>. In human, these are designated Akt1, Akt2, and Akt3, (PKB &#x003b1;, &#x003b2; and &#x003b3;) and are located at chromosomes 14q32, 19q13 and 1q44, respectively <xref ref-type="bibr" rid="pone.0007523-Bellacosa2">&#x0005b;4&#x0005d;</xref>.</p><p>Akt kinases are classically activated by engagement of receptor tyrosine kinases by peptide growth factors and cytokines, as well as oxidative stress and heat shock. Akt activation depends on PtdIns-3,4,5-P<sub>3</sub> and to a lesser extent on PtdIns-4,5-P<sub>2</sub>, which are products of phosphoinositide 3-kinase <xref ref-type="bibr" rid="pone.0007523-Franke1">&#x0005b;PI3K, 5&#x0005d;</xref>. The interaction of PtdIns-3,4,5-P<sub>3</sub> with the PH domain of Akt1 favors the interaction with their upstream activators and its phosphorylation at two sites: one in the activation loop (Thr<sup>308</sup>) and another in the C-terminal tail (Ser<sup>473</sup>). Phosphorylation at Ser<sup>473</sup> appears to precede and facilitate phosphorylation at Thr<sup>308</sup><xref ref-type="bibr" rid="pone.0007523-Sarbassov1">&#x0005b;6&#x0005d;</xref>. Akt1 is phosphorylated in Ser<sup>473</sup> by subunits SIN1 and MIP1 of mTORC2 complex <xref ref-type="bibr" rid="pone.0007523-Jacinto1">&#x0005b;rapamycin&#x0005d;</xref>-<xref ref-type="bibr" rid="pone.0007523-Ikenoue1">&#x0005b;insensitive companion of mTOR, 7, 8&#x0005d;</xref> while the kinase responsible for phosphorylation in Thr<sup>308</sup> is PI3K-dependent kinase 1 <xref ref-type="bibr" rid="pone.0007523-Chan1">&#x0005b;PDK1, 9&#x0005d;</xref>. Of note, the S473D mutant of Akt1 and Akt1 phosphorylated in Ser<sup>473</sup> by the rictor-mTOR complex are better targets of PDK1 than nonphosphorylated Akt1 <xref ref-type="bibr" rid="pone.0007523-Sarbassov1">&#x0005b;6&#x0005d;</xref>. These findings suggest that phosphorylation at Ser<sup>473</sup> may provide a docking site for PDK1 <xref ref-type="bibr" rid="pone.0007523-Frdin1">&#x0005b;10&#x0005d;</xref>. Once activated, Akt not only phosphorylates an ever-expanding list of substrates in cytosol but also can translocate to nuclei and mitochondria <xref ref-type="bibr" rid="pone.0007523-Bijur1">&#x0005b;11&#x0005d;</xref>. Furthermore, our group has previously demonstrated that mitochondrial Akt2 is an essential mediator for the regulation of muscle O<sub>2</sub> utilization upon insulin stimulation <xref ref-type="bibr" rid="pone.0007523-Finocchietto1">&#x0005b;12&#x0005d;</xref>.</p><p>Recent data strongly suggest that in addition to signaling cascades initiated by hormones or growth factors, reactive oxygen species (ROS) are involved in physiological signaling pathways that regulate a variety of cellular functions and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) is the main messenger molecule <xref ref-type="bibr" rid="pone.0007523-Carreras1">&#x0005b;13&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007523-Carreras2">&#x0005b;14&#x0005d;</xref>. Mitochondria are suitable as a point of integration for these signaling pathways due to their critical role in cellular metabolism, redox balance, and survival-death mechanisms.</p><p>Research on mitochondria has focused on bioenergetics, biogenesis and the regulation of apoptotic cell death through mechanisms which have been conserved through evolution <xref ref-type="bibr" rid="pone.0007523-Green1">&#x0005b;15&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0007523-VanderHelden1">&#x0005b;17&#x0005d;</xref>. Proliferation is associated with low mitochondrial respiration <xref ref-type="bibr" rid="pone.0007523-VanderHelden1">&#x0005b;the Warburg effect, 17&#x0005d;</xref> and tumoral mitochondria only retain 10&#x02013;50&#x00025; of the activity of complexes I, II&#x02013;III, and IV of quiescent tissues <xref ref-type="bibr" rid="pone.0007523-Nogueira1">&#x0005b;18&#x0005d;</xref>. Akt can increase or decrease mitochondrial respiration <xref ref-type="bibr" rid="pone.0007523-Finocchietto1">&#x0005b;12&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007523-Galli1">&#x0005b;19&#x0005d;</xref> but in spite of extensive research on death mediators and survival mechanisms <xref ref-type="bibr" rid="pone.0007523-Cory1">&#x0005b;20&#x0005d;</xref>, little is known about cell communication in terms of Akt trafficking into the organelles, the basis for intramitochondrial signaling.</p><p>In the present work, we adopted a novel approach to elucidate whether Akt1 sequential phosphorylation is related to the modulation of cell fate by its redox state. We demonstrate that the second phosphorylation of Akt1 in Thr<sup>308</sup> occurs in mitochondria and that this effect is blunted at high redox state, thus eliciting different responses, either proliferation or apoptosis in the NIH/3T3 cells.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>The fate of NIH/3T3 cells depends on the redox status</title><p>To test contextual effects of varying redox status, NIH/3T3 cells were incubated with 50&#x02013;1000 &#x000b5;M H<sub>2</sub>O<sub>2</sub> for 24&#x02013;48 h. At 50 &#x000b5;M H<sub>2</sub>O<sub>2</sub>, cell proliferation rate doubled (<xref ref-type="fig" rid="pone-0007523-g001">Fig. 1A</xref>) and cyclin D1 expression was up-regulated (<xref ref-type="fig" rid="pone-0007523-g001">Fig. 1B</xref>); proliferation rise at low H<sub>2</sub>O<sub>2</sub> was hindered by the PI3K inhibitor LY294002, thus indicating that cell duplication mainly occurred through the PI3K-Akt pathway (<xref ref-type="fig" rid="pone-0007523-g001">Fig. 1A</xref>). Conversely, 250 &#x000b5;M H<sub>2</sub>O<sub>2</sub> caused a decrease of cell proliferation and cyclin D1 expression (<xref ref-type="fig" rid="pone-0007523-g001">Fig. 1A and B</xref>); proliferation was completely abrogated at 1 mM H<sub>2</sub>O<sub>2</sub>. Annexin V-propidium iodide double-positive cells and hypodiploid peak in flow cytometry indicated that high H<sub>2</sub>O<sub>2</sub> concentration triggered apoptosis (<xref ref-type="fig" rid="pone-0007523-g001">Fig. 1C</xref> and <xref ref-type="supplementary-material" rid="pone.0007523.s001">S1</xref>, <xref ref-type="supplementary-material" rid="pone.0007523.s007">Methods S1</xref>). Irrespective of the H<sub>2</sub>O<sub>2</sub> concentration, the percentage of apoptosis was increased by LY294002 inhibition of PI3K (<xref ref-type="fig" rid="pone-0007523-g001">Fig. 1C</xref>). Apoptosis was achieved upon activation of the mitochondrial caspase-3-dependent pathway resulting in the release of cytochrome <italic>c</italic> to cytosol (<xref ref-type="fig" rid="pone-0007523-g001">Fig. 1D</xref>) and concomitant loss of mitochondrial membrane potential (<xref ref-type="supplementary-material" rid="pone.0007523.s002">Fig. S2</xref> and <xref ref-type="supplementary-material" rid="pone.0007523.s005">Table S1</xref>, <xref ref-type="supplementary-material" rid="pone.0007523.s008">Methods S2</xref> and <xref ref-type="supplementary-material" rid="pone.0007523.s009">S3</xref>). Redox changes were accompanied by variations in the redistribution of Bcl proteins; there was retention of the antiapoptotic protein Bcl-x<sub>L</sub> in mitochondria upon high redox stimulation (<xref ref-type="fig" rid="pone-0007523-g001">Fig. 1D</xref>). These results indicate that a) at low H<sub>2</sub>O<sub>2</sub> proliferation is stimulated in NIH/3T3 cells <italic>via</italic> Akt and b) at high oxidant level Akt is down-regulated and the mitochondrial proapoptotic pathways are activated.</p><fig id="pone-0007523-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007523.g001</object-id><label>Figure 1</label><caption><title>Hydrogen peroxide is the single signal that triggers cell proliferation or conducts to apoptosis.</title><p>(A) H<sub>2</sub>O<sub>2</sub> modulates cell proliferation rate through the Akt pathway; &#x0005b;<sup>3</sup>H&#x0005d; thymidine incorporation was measured 48 h after supplementing cells with H<sub>2</sub>O<sub>2</sub> (C&#x0200a;&#x0003d;&#x0200a;control). Data are mean &#x000b1; s.e.m; n&#x0200a;&#x0003d;&#x0200a;8, experiment representative of 5, &#x0002a;<italic>p</italic>&#x0003c;0.05 <italic>vs</italic> C. When appropriate, cells were preincubated 2 h prior to redox stimulation with 80 &#x000b5;M PI3K/Akt inhibitor (LY294002) (<sup>#</sup><italic>p</italic>&#x0003c;0.05 <italic>vs</italic> H<sub>2</sub>O<sub>2</sub> inhibition). The inhibitor reduced the proliferation rate by 50&#x02013;75&#x00025; between 0 and 50 &#x000b5;M H<sub>2</sub>O<sub>2</sub>, thus indicating dependence on Akt of redox effects on cell proliferation. (B) The redox variations of cyclin D1 paralleled those of the proliferation rate. (C) At higher concentration of H<sub>2</sub>O<sub>2</sub>, apoptosis increased by 10 fold as determined by flow cytometry with Annexin V staining (upper panel) and propidium iodide (medium panel) 48 h after H<sub>2</sub>O<sub>2</sub> treatment. In the lower panel, the relationship between Akt inhibition and apoptosis is represented (red circles correspond to 50 &#x000b5;M H<sub>2</sub>O<sub>2</sub> and black ones to 250 &#x000b5;M H<sub>2</sub>O<sub>2</sub>). (D) Expression of active caspase 3 (upper panel) and translocation of Bcl-x<sub>L</sub> and cytochrome <italic>c</italic> from mitochondria (medium panel) to cytosol (lower panel) were determined 24 and 48 h after H<sub>2</sub>O<sub>2</sub><monospace>, </monospace>as markers of mitochondrial apoptotic pathways.</p></caption><graphic xlink:href="pone.0007523.g001"/></fig></sec><sec id="s2b"><title>The kinetics of cell trafficking and Akt1 redistribution upon redox stimuli</title><p>Akt is at the crossroad of several mitochondrion-mediated cell death pathways and constitutes an important target for cancer therapy. Here we show that cell cycle modulation by H<sub>2</sub>O<sub>2</sub> is orchestrated by the Akt pathway in mitochondria. It has been previously reported that insulin-like growth factor 1 results in rapid translocation of P-Akt into mitochondria of neuroblastoma and human embryonic kidney cells <xref ref-type="bibr" rid="pone.0007523-Bijur1">&#x0005b;11&#x0005d;</xref>.</p><p>The mitochondrial contribution in Akt1 activation was examined by redistribution of cellular Akt1 at the different H<sub>2</sub>O<sub>2</sub> concentrations (<xref ref-type="fig" rid="pone-0007523-g002">Fig. 2A and B</xref>). Cell exposure to low H<sub>2</sub>O<sub>2</sub> concentration caused a prompt appearance of Akt1 in mitochondria, cytosol, and nuclei that further decayed to the basal level. At high H<sub>2</sub>O<sub>2</sub>, Akt1 content increased slowly and largely retained in mitochondria, along with a discrete increase in cytosol and nuclei. To test whether a deficient traffic of Akt1 to mitochondria and nuclei depends on abnormal phosphorylations at Ser<sup>473</sup> or Thr<sup>308</sup>, we compared the respective kinetics at the different redox status. At low H<sub>2</sub>O<sub>2</sub>, the kinetics of activation and redistribution of P-Akt1 Ser<sup>473</sup> and P-Akt1 Thr<sup>308</sup> mimicked those of total Akt1 (<xref ref-type="fig" rid="pone-0007523-g002">Fig. 2A and B</xref>); a slight delay of P-Akt1 Thr<sup>308</sup> peak agreed with the conventional sequence for the two phosphorylation events <xref ref-type="bibr" rid="pone.0007523-Sarbassov1">&#x0005b;6&#x0005d;</xref>. Instead at high H<sub>2</sub>O<sub>2</sub>, phosphorylation of Thr<sup>308</sup> was almost undetectable either in mitochondria or nuclei. Moreover, the peak of phosphorylation at Ser<sup>473</sup> was not essentially modified though delayed and, P-Akt1 Ser<sup>473</sup> was retained in mitochondria during the entire procedure (<xref ref-type="fig" rid="pone-0007523-g002">Fig. 2A and B</xref>). It is worthnoting that a) phosphorylation at Thr<sup>308</sup> stimulates the rate of mitochondrial uptake of P-Akt1 Ser<sup>473</sup>; b) the retention of monophosphorylated P-Akt1 Ser<sup>473</sup> in mitochondria and slow redistribution to nuclei reveal the interdependence of the two compartments; c) in this framework, experimental data clearly reveals the sequence of the subcellular traffic of Akt1: mitochondria to nucleus, and d) the second mitochondrial Akt1 phosphorylation in Thr<sup>308</sup> drives the NIH redox transition from proliferation to apoptosis (<xref ref-type="fig" rid="pone-0007523-g001">Fig. 1C</xref>). No contamination of the different fractions was detected as assessed by western blot and enzymatic activities measurement (<xref ref-type="supplementary-material" rid="pone.0007523.s003">Fig. S3</xref> and <xref ref-type="supplementary-material" rid="pone.0007523.s006">Table S2</xref>, <xref ref-type="supplementary-material" rid="pone.0007523.s010">Methods S4</xref>).</p><fig id="pone-0007523-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007523.g002</object-id><label>Figure 2</label><caption><title>Kinetics of Akt1 activation and subcellular redistribution upon redox stimuli.</title><p>In (A) and (B), western blots and curves represent the differential subcellular traffic, mitochondrial retention and activation of Akt1 at the proliferating and the apoptotic phases. Kinetics of the temporal distribution of P-Akt1Ser<sup>473</sup> (black circles) and P-Akt1Thr<sup>308</sup> (red circles) in the subcellular fractions are followed at 50 and 250 &#x000b5;M H<sub>2</sub>O<sub>2</sub>. Total Akt1 was evaluated in the same redox conditions (black circles correspond to 50 &#x000b5;M H<sub>2</sub>O<sub>2</sub> and green ones to 250 &#x000b5;M H<sub>2</sub>O<sub>2</sub>). In (B), each point integrates densitometries from three separate experiments; &#x0002a;<italic>p</italic>&#x0003c;0.05. Protein loading was determined with antibodies anti complex I for mitochondria, &#x003b2;-actin for cytosol, and RNA POL RPB6 for nuclei.</p></caption><graphic xlink:href="pone.0007523.g002"/></fig></sec><sec id="s2c"><title>Akt1 interacts with upstream PDK1 in mitochondria</title><p>It was recently established that Akt1 phosphorylation at Ser<sup>473</sup> is catalyzed by mTORC2 complex <xref ref-type="bibr" rid="pone.0007523-Ikenoue1">&#x0005b;8&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0007523-Cory1">&#x0005b;20&#x0005d;</xref> while phosphorylation at Thr<sup>308</sup> is catalyzed by P-PDK1 <xref ref-type="bibr" rid="pone.0007523-Chan1">&#x0005b;9&#x0005d;</xref>. Both phosphorylations are thought to occur in the cell plasma membrane as driven by Pleckstrin homology domains that interact with PI3K in the hydrophobic phase. However, after mitochondrial sub-fractionation we found both Akt1 and upstream P-PDK1 in the mitochondrial outer membrane and intermembrane space of NIH/3T3 cells; PDK1 was also present in the inner mitochondrial membrane (<xref ref-type="fig" rid="pone-0007523-g003">Fig. 3A</xref>). Instead, mTORC2 was expressed in plasma membrane and cytosol but poorly expressed in mitochondria (<xref ref-type="fig" rid="pone-0007523-g003">Fig. 3B</xref>). To explore the effects of H<sub>2</sub>O<sub>2</sub> on Akt1-PDK1 interaction, we performed pull-down assays with human recombinant Akt1-GST bound to agarose beads, previously treated with 0.1&#x02013;25 &#x000b5;M H<sub>2</sub>O<sub>2</sub>, and subsequently incubated with the mitochondrial fractions. Akt1-GST binding to PDK1 was enhanced at low H<sub>2</sub>O<sub>2</sub> level (1 &#x000b5;M H<sub>2</sub>O<sub>2</sub>) while oxidation of Akt1-GST exposed to high H<sub>2</sub>O<sub>2</sub> yield (10 &#x000b5;M H<sub>2</sub>O<sub>2</sub>) disrupted the Akt1-PDK1 interaction (<xref ref-type="fig" rid="pone-0007523-g003">Fig. 3C</xref>). To evaluate the redox effects on Akt1 activity in the same conditions, we immunoprecipitated Akt1 from cytosolic, mitochondrial and nuclear extracts of NIH cells treated with different H<sub>2</sub>O<sub>2</sub> concentrations and measured the formation of P-GSK-3 &#x003b1;/&#x003b2; in an <italic>in vitro</italic> assay. In agreement with the former result on Akt interaction with PDK1, Akt1 activity in the organelles was enhanced by 150&#x00025; at low H<sub>2</sub>O<sub>2</sub> and decreased to 45&#x00025; of control at high H<sub>2</sub>O<sub>2</sub> yield (<xref ref-type="fig" rid="pone-0007523-g003">Fig. 3D</xref>).</p><fig id="pone-0007523-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007523.g003</object-id><label>Figure 3</label><caption><title>Akt1 activity relies on the H<sub>2</sub>O<sub>2</sub>-dependent adjustment of the binding to P-PDK1 in mitochondria.</title><p>(A) Akt1 and P-PDK1 are localized in the mitochondrial outer membrane and the intermembrane space. Submitochondrial localization was assessed by western blot. (M: mitochondria; Mpl: mitoplast; OMM: outer mitochondrial membrane; IMS: intermembrane space; IMM: inner mitochondrial membrane; Mx: mitochondrial matrix). Identity of mitochondrial fractions was corroborated with specific antibodies anti complex I 39 kDa subunit, voltage-dependent anion channel (VDAC1), superoxide dismutase II and cytochrome <italic>c</italic>. (B) mTORC2 is mainly localized in vesicle fractions. (C) P-PDK1 and Akt1 interaction is enhanced at low H<sub>2</sub>O<sub>2</sub> condition while binding is abolished at high redox status. Human recombinant Akt1-GST was immobilized on agarose, oxidized with H<sub>2</sub>O<sub>2</sub> and incubated with mitochondrial fraction. P-PDK1 was detected by western blot. (D) Akt1 activity is modulated by the redox status. The activity was detected through the level of phosphorylation of GSK-3 &#x003b1;/&#x003b2; substrate in mitochondria, cytosol and nuclei.</p></caption><graphic xlink:href="pone.0007523.g003"/></fig></sec><sec id="s2d"><title>Akt1 traffic to the nucleus requires phosphorylation at Thr<sup>308</sup> in mitochondria</title><p>To assess Akt1 mitochondria-nucleus functional connection and the significance of intramitochondrial Akt1 phosphorylation by PDK1, we obtained Akt1 T308A by directed mutagenesis, which renders a non-phosphorylatable mutant at Thr<sup>308</sup>. Cells transfected with wt Akt1 and stimulated with 50 &#x000b5;M H<sub>2</sub>O<sub>2</sub> behaved similarly to the previous results (<xref ref-type="fig" rid="pone-0007523-g004">Fig. 4A</xref>); Akt1 translocation was maximal at 5&#x02013;10 min and further decreased in mitochondria while increased in the nuclei. On the contrary, Akt1 T308A accumulated in mitochondria and did not translocate to but rather decreased in nuclei suggesting that complete activation of Akt1 and further shuttle to nuclei depend on the phosphorylation in Thr<sup>308</sup> by mitochondrial PDK1 (<xref ref-type="fig" rid="pone-0007523-g004">Fig. 4A</xref>). Accordingly, Akt1 T308A transfected cells did not elicite an increase in cyclin D1 expression whereas the apoptotic machinery was activated <italic>via</italic> caspase-3 (<xref ref-type="fig" rid="pone-0007523-g004">Fig. 4B</xref>).</p><fig id="pone-0007523-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007523.g004</object-id><label>Figure 4</label><caption><title>Complete activation of Akt1 and efficient shuttle to nuclei critically depend on mitochondrial phosphorylation of Thr<sup>308</sup>.</title><p>(A) Akt mutation in Thr<sup>308</sup> causes kinase retention in mitochondria and prevents final shuttle to nucleus. Kinetics of differential mitochondrial, cytosolic and nuclear distribution of transfected wild type and T308A Akt were followed by western blot after 50 &#x000b5;M H<sub>2</sub>O<sub>2</sub> treatment. (B) Prevention of Akt1T308A translocation to nucleus causes a decrease in cyclin D1 expression and a rise in caspase 3 level. (C) NIH/3T3 cells were transfected with Akt1-GFP, Akt1 S473A-GFP or Akt1 T308A-GFP and stained with MitoTracker Deep Red. Images of GFP and MitoTracker fluorescence intensity individual and merged channels are shown. Bar &#x0200a;&#x0003d;&#x0200a;10 &#x000b5;m. GFP mean fluorescence intensity was quantified in cytosol, mitochondria or nuclei and normalized to whole cell mean GFP fluorescence. In (D), zoom of the green, red and merged images. Manders overlap and Pearson's correlation coefficient maps are included. Color bar &#x0200a;&#x0003d;&#x0200a; single pixel contribution to the overall coefficient. On the right panel, statistical analysis of hAkt1 localization to mitochondria. Upper panels: the probability distribution of random colocalization was obtained by computing the the Pearson's correlation coefficient (21) or Manders overlap coefficient (Villalta <italic>et al</italic>., in preparation) after repetitively scrambling the pixel positions in the green hAkt1T308A-GFP zoomed image. Red line &#x0200a;&#x0003d;&#x0200a; normal distribution adjusted to the data. Lower panel: Manders overlap and Pearson's correlation coefficient values were estimated for the zoomed images.</p></caption><graphic xlink:href="pone.0007523.g004"/></fig><p>Real time video imaging confirmed this Akt1 distribution at the different times (<xref ref-type="fig" rid="pone-0007523-g004">Fig. 4C</xref>, <xref ref-type="supplementary-material" rid="pone.0007523.s002">S2</xref> and <xref ref-type="supplementary-material" rid="pone.0007523.s013">Videos S1</xref>&#x02013;<xref ref-type="supplementary-material" rid="pone.0007523.s016">S4</xref>). In these experiments, NIH/3T3 cells were transfected with wt Akt1-GFP or the respective mutants that lack one of the phosphorylation sites, Akt1 T308A-GFP and Akt1 S473A-GFP, and further stained with a specific mitochondrial marker, MitoTracker Deep Red, and analyzed by confocal microscopy. In these conditions, stimulation with 50 &#x000b5;M H<sub>2</sub>O<sub>2</sub> differently redistributed wt Akt1-GFP and the mutants among the different subcellular compartments (<xref ref-type="fig" rid="pone-0007523-g004">Fig. 4C</xref>, <xref ref-type="supplementary-material" rid="pone.0007523.s002">S2</xref> and <xref ref-type="supplementary-material" rid="pone.0007523.s013">Videos S1</xref>-<xref ref-type="supplementary-material" rid="pone.0007523.s016">S4</xref>). Wild type Akt1-GFP traversed mitochondria rapidly and localized predominantly in nuclei (intense green nuclei) whereas Akt1 S473A-GFP localization to nuclei and mitochondria was modest. Akt1 T308A-GFP was accumulated in mitochondria during 0&#x02013;15 min in detriment to its nuclear localization. Akt1 T308A-GFP preferential retention in mitochondria and the scarce Akt1 S473A-GFP presence in the organelle were appreciated in enlarged views of the images (<xref ref-type="fig" rid="pone-0007523-g004">Fig. 4D</xref>). In addition, the Pearson's correlation coefficient and Manders overlap coefficient maps clearly show a higher contribution to the colocalization of the pixels enclosed in the mitochondrial region (intense red color), which indicates that those pixels display high green (GFP) and red (MitoTracker) fluorescence intensity (details in <xref ref-type="supplementary-material" rid="pone.0007523.s011">Methods S5</xref>). The coefficient value was further determined for the images in <xref ref-type="fig" rid="pone-0007523-g004">figure 4D</xref>. For Akt1 T308A-GFP both coefficient values were positive and high and significantly above those expected for random generated images (see distribution coefficients for random images in <xref ref-type="fig" rid="pone-0007523-g004">figure 4D</xref>, bar graphs) <xref ref-type="bibr" rid="pone.0007523-Costes1">&#x0005b;21&#x0005d;</xref> which argues for true non-fortuitous superposition of randomly distributed fluorophores. Instead, the coefficients resulted near zero (Manders overlap) or negative (Pearson's correlation) for Akt1 S473A-GFP, which indicate lack or minimal colocalization. These results confirm that the sequential phosphorylation of Akt1 is strictly necessary for the regulation of the kinase redistribution among the cellular compartments: Ser<sup>473</sup> phosphorylation is central for kinase translocation to mitochondria and mitochondrial Thr<sup>308</sup> phosphorylation is crucial for Akt1 traffic to nucleus.</p></sec><sec id="s2e"><title>Akt1 requires to be phosphorylated at Ser<sup>473</sup> to enter mitochondria &#x0201c;<italic>ex vivo</italic>&#x0201d;</title><p>To elucidate the complete cycle of Akt1 phosphorylation, recombinant hAkt1-his tagged was incubated with isolated NIH mitochondria before and after being monophosphorylated <italic>in vitro</italic> with brain mTORC2. It is shown here (<xref ref-type="fig" rid="pone-0007523-g005">Fig. 5A and B</xref>) that inactive Akt1 cannot enter to isolated energized mitochondria. Instead, P-Akt1 Ser<sup>473</sup> enters mitochondria very fast up to a relative rate of 1.2 pg/min.&#x003bc;g prot. An almost complete decay of mitochondrial P-Akt1 Ser<sup>473</sup> was observed in the isolated organelles at 50 min. By that time, Akt1 concentration increased in the supernatant by one-fold and the data indicated a reverse in the net flux of Akt1 among the two compartments. Furthermore, we examined whether mtP-Akt1 Ser<sup>473</sup> had been modified in isolated mitochondria, <italic>i.e.</italic>, by acquiring the second phosphorylation. By utilizing the antibody anti P-Thr<sup>308</sup>, we confirmed that P-Akt1 Ser<sup>473</sup> had been phosphorylated in mitochondria to P-Akt1 Ser<sup>473</sup>/Thr<sup>308</sup>, the completely active variant of the kinase (<xref ref-type="fig" rid="pone-0007523-g005">Fig. 5A and B</xref>).</p><fig id="pone-0007523-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007523.g005</object-id><label>Figure 5</label><caption><title>The mitochondrial cycle of Akt1 under redox stimuli.</title><p>In (A) and (B), Akt1 requires to be phosphorylated in Ser<sup>473</sup> to enter mitochondria. Inactive Akt1-His tagged and mTORC2 were incubated in kinase buffer to allow phosphorylation. In absence of P-mTORC2 Akt1 remains outside mitochondria, In the presence of mTORC2, P-Akt Ser<sup>473</sup> translocates to mitochondria and becomes phosphorylated in Thr<sup>308</sup>; approximately after 50 min biphosphorylated P-Akt Ser<sup>473</sup>/Thr<sup>308</sup> becomes detectable in the supernatant. These extracts were incubated with purified mitochondria in import buffer and the samples were centrifuged and prepared to run in SDS-PAGE. (C) Imaging of wb using a His-tag ab anti mouse conjugated to Cy3 and a P-Thr308 ab anti rabbit conjugated to Cy2 shows colocalization (yellow) in the presence of P-mTORC2. Addition of PDK1 alone is unable to phosphorylate Akt1 in Thr<sup>308</sup>.</p></caption><graphic xlink:href="pone.0007523.g005"/></fig></sec><sec id="s2f"><title>Mitochondria and plasma membrane cooperate for complete Akt1 activation <italic>in vitro</italic> in reconstituted vesicles</title><p>To confirm that mitochondria and plasma membrane are essential for Akt1 complete activation, inactive recombinant hAkt1 was subjected to oxidation by H<sub>2</sub>O<sub>2</sub> (0.1 &#x000b5;M) and incubated with membrane vesicles purified from the NIH cells alone and with vesicles that engulfed a preparation of NIH mitoplasts in a proportion of 10&#x02013;100 mitoplasts per vesicle. Vesicles were specifically labeled with an antibody that recognizes membrane ATPase and a secondary antibody conjugated with Cy3. Mitoplasts were specifically stained with MitoTracker Deep Red. The particles were also incubated with antibodies against P-Akt1 Ser<sup>473</sup> or P-Akt1 Thr<sup>308</sup> and secondary antibodies conjugated to Cy2. In the confocal microscope images, red particles account for vesicles, blue particles for mitoplasts and fusion particles are shown in magenta (<xref ref-type="fig" rid="pone-0007523-g006">Fig. 6A</xref>). P-Akt1 Ser<sup>473</sup>-Cy2 label was observed predominantly in vesicles that contained no or little mitoplast stain (<xref ref-type="fig" rid="pone-0007523-g006">Fig. 6A</xref>, bars) but contained mTORC2 (<xref ref-type="fig" rid="pone-0007523-g003">Fig. 3B</xref>). Instead, these vesicles did not cause P-Akt1 Thr<sup>308</sup>-Cy2. This fact indicates that a) the first Akt1 phosphorylation depends on plasma membrane; b) in the absence of mitochondria that participates in the phosphorilation of P-Akt1 Ser<sup>473</sup>-Cy2 at Thr<sup>308</sup>, the kinase is accumulated in the vesicles. Instead, we observed the highest P-Akt1 Thr<sup>308</sup>-Cy2 and the lowest P-Akt1 Ser<sup>473</sup>-Cy2 fluorescence intensity in those vesicles that contained predominant mitoplast stain (<xref ref-type="fig" rid="pone-0007523-g006">Fig. 6A</xref>, bars). Because the first phosphorylation does not occur in the absence of vesicles, mitoplasts by themselves were not capable to accomplish Thr<sup>308</sup> phosphorylation. These results show that plasma and mitochondrial membranes cooperate for complete Akt activation in NIH cells, and confirm that Ser<sup>473</sup> phosphorylation is a prerequisite for Thr<sup>308</sup> phosphorylation to occur in mitoplasts. A scheme of double Akt1 phosphorylation in the different subcellular localizations is summarized in <xref ref-type="fig" rid="pone-0007523-g006">Figure 6B</xref>.</p><fig id="pone-0007523-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007523.g006</object-id><label>Figure 6</label><caption><title>The sinergy between plasma and mitochondrial membranes in Akt double phosphorylation.</title><p>(A) Second Akt1 phosphorylation in Thr<sup>308</sup> occurs in mitoplasts. Vesicles and mitoplasts were isolated from NIH/3T3 cells, and co-incubated in the presence of Akt1 in an import assay (see methods). The preparations were labeled with MitoTracker Deep Red to identify mitoplasts and further fixed and labeled with an antibody against ATPase and a second antibody conjugated with Cy3 to recognize vesicles. P-Ser<sup>473</sup> or P-Thr<sup>308</sup> were labeled with specific antibodies and a second antibody conjugated with Cy2. Green (Akt), red (vesicles), blue (mitoplasts) and merged images are shown. Bar &#x0200a;&#x0003d;&#x0200a;10 &#x000b5;m. On the right, Cy2 (Ser or Thr), Cy3 (ATPase) and MitoTracker Deep Red fluorescence intensity was measured on every vesicle, mitoplast or fusion particle (vesicle &#x0002b; mitoplast) in the images (see methods). Particle populations were partitioned in accord to its prevalent label: mainly vesicles (red bar), mainly mitoplasts (blue bar) or both stains (yellow bar) using k-means clustering method. Cy2 fluorescence intensity was compared in these three populations. (B) Scheme of Akt1 sequential phosphorylation, activation and consequent subcelullar redistribution under opposite redox states.</p></caption><graphic xlink:href="pone.0007523.g006"/></fig></sec><sec id="s2g"><title>Akt1 Cys<sup>60</sup> and Cys<sup>310</sup> are main targets for H<sub>2</sub>O<sub>2</sub> oxidation</title><p>Mass spectrometry analysis of recombinant Akt1 incubated <italic>in vitro</italic> with different H<sub>2</sub>O<sub>2</sub> concentrations (representative of those utilized in the <italic>in vivo</italic> assays) are shown in <xref ref-type="table" rid="pone-0007523-t001">Table 1</xref>. In non-stimulated cells only Cys<sup>310</sup> (which is adjacent (&#x0223c;5 &#x000c5;) to Thr<sup>308</sup>) was oxidized to sulfenic acid. With increasing H<sub>2</sub>O<sub>2</sub> concentrations, Cys<sup>310</sup> remained partly as sulfenic acid (Cys-SOH) and partly oxidized further to cysteic or sulfonic acid (Cys-SO<sub>3</sub><sup>3&#x02212;</sup>). At 1 &#x000b5;M H<sub>2</sub>O<sub>2</sub> Cys<sup>310</sup> was always modified as cysteic acid. In addition, Cys<sup>60</sup> in the PH domain was not modified in non-stimulated cells or at very low H<sub>2</sub>O<sub>2</sub> but resulted every time oxidized to cysteic acid from 0.1 to 20 &#x000b5;M.</p><table-wrap id="pone-0007523-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0007523.t001</object-id><label>Table 1</label><caption><title>Mass spect of oxidized recombinant Akt1.</title></caption><alternatives><graphic id="pone-0007523-t001-1" xlink:href="pone.0007523.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">H<sub>2</sub>O<sub>2</sub> (&#x003bc;M)</td><td align="left" rowspan="1" colspan="1">tryptic peptide</td><td align="left" rowspan="1" colspan="1">residue</td><td align="left" rowspan="1" colspan="1">prob.</td><td align="left" rowspan="1" colspan="1">MSc&#x0002a;</td><td align="left" rowspan="1" colspan="1">modification</td><td align="left" rowspan="1" colspan="1">&#x00394;cn&#x0002a;&#x0002a;</td><td align="left" rowspan="1" colspan="1">peptide charge</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">none</td><td align="left" rowspan="1" colspan="1">EAPLNNFSVAQCQLMK</td><td align="left" rowspan="1" colspan="1">Cys<sup>60</sup></td><td align="left" rowspan="1" colspan="1">95&#x00025;</td><td align="left" rowspan="1" colspan="1">75.5</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">0.55</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">TFC<sup>&#x0002b;16</sup>GTPEYLAPEVLEDNDYGR</td><td align="left" rowspan="1" colspan="1">Cys<sup>310</sup></td><td align="left" rowspan="1" colspan="1">71&#x00025;</td><td align="left" rowspan="1" colspan="1">34.2</td><td align="left" rowspan="1" colspan="1">Sulfenic acid (&#x0002b;16)</td><td align="left" rowspan="1" colspan="1">&#x02212;0.40</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">0.001</td><td align="left" rowspan="1" colspan="1">EAPLNNFSVAQCQLMK</td><td align="left" rowspan="1" colspan="1">Cys<sup>60</sup></td><td align="left" rowspan="1" colspan="1">95&#x00025;</td><td align="left" rowspan="1" colspan="1">75.5</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">0.55</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">EAPLNNFSVAQCQLMK</td><td align="left" rowspan="1" colspan="1">Cys<sup>60</sup></td><td align="left" rowspan="1" colspan="1">95&#x00025;</td><td align="left" rowspan="1" colspan="1">66.6</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">0.038</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">EAPLNNFSVAQCQLMK</td><td align="left" rowspan="1" colspan="1">Cys<sup>60</sup></td><td align="left" rowspan="1" colspan="1">95&#x00025;</td><td align="left" rowspan="1" colspan="1">66.3</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">0.33</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">0.01</td><td align="left" rowspan="1" colspan="1">EAPLNNFSVAQCQLMK</td><td align="left" rowspan="1" colspan="1">Cys<sup>60</sup></td><td align="left" rowspan="1" colspan="1">95&#x00025;</td><td align="left" rowspan="1" colspan="1">75.51</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02212;0.79</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">TFC&#x0002b;<sup>16</sup>GTPEYLAPEVLEDNDYGR</td><td align="left" rowspan="1" colspan="1">Cys<sup>310</sup></td><td align="left" rowspan="1" colspan="1">94&#x00025;</td><td align="left" rowspan="1" colspan="1">41.25</td><td align="left" rowspan="1" colspan="1">Sulfenic acid (&#x0002b;16)</td><td align="left" rowspan="1" colspan="1">&#x02212;0.58</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">TFC<sup>&#x0002b;48</sup>GTPEYLAPEVLEDNDYGR</td><td align="left" rowspan="1" colspan="1">Cys<sup>310</sup></td><td align="left" rowspan="1" colspan="1">95&#x00025;</td><td align="left" rowspan="1" colspan="1">57.2</td><td align="left" rowspan="1" colspan="1">Sulfenic acid (&#x0002b;16)</td><td align="left" rowspan="1" colspan="1">0.43</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">TFC<sup>&#x0002b;48</sup>GTPEYLAPEVLEDNDYGR</td><td align="left" rowspan="1" colspan="1">Cys<sup>310</sup></td><td align="left" rowspan="1" colspan="1">88&#x00025;</td><td align="left" rowspan="1" colspan="1">39.06</td><td align="left" rowspan="1" colspan="1">Cysteic acid (&#x0002b;48)</td><td align="left" rowspan="1" colspan="1">0.066</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">0.1</td><td align="left" rowspan="1" colspan="1">EAPLNNFSVAQCQLMK</td><td align="left" rowspan="1" colspan="1">Cys<sup>60</sup></td><td align="left" rowspan="1" colspan="1">95&#x00025;</td><td align="left" rowspan="1" colspan="1">77.4</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02212;0.17</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">EAPLNNFSVAQC<sup>&#x0002b;48</sup>QLMK</td><td align="left" rowspan="1" colspan="1">Cys<sup>310</sup></td><td align="left" rowspan="1" colspan="1">95&#x00025;</td><td align="left" rowspan="1" colspan="1">65.8</td><td align="left" rowspan="1" colspan="1">Cysteic acid (&#x0002b;48)</td><td align="left" rowspan="1" colspan="1">0.79</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">TFC<sup>&#x0002b;48</sup>GTPEYLAPEVLEDNDYGR</td><td align="left" rowspan="1" colspan="1">Cys<sup>310</sup></td><td align="left" rowspan="1" colspan="1">88&#x00025;</td><td align="left" rowspan="1" colspan="1">45.4</td><td align="left" rowspan="1" colspan="1">Cysteic acid (&#x0002b;48)</td><td align="left" rowspan="1" colspan="1">&#x02212;0.33</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">TFC<sup>&#x0002b;48</sup>GTPEYLAPEVLEDNDYGR</td><td align="left" rowspan="1" colspan="1">Cys<sup>310</sup></td><td align="left" rowspan="1" colspan="1">95&#x00025;</td><td align="left" rowspan="1" colspan="1">62.9</td><td align="left" rowspan="1" colspan="1">Cysteic acid (&#x0002b;48)</td><td align="left" rowspan="1" colspan="1">0.76</td><td align="left" rowspan="1" colspan="1">2</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><p>hAkt1 (1 &#x000b5;g/50 &#x000b5;l) was oxidized by 15 min in 1X kinase buffer (Calbiochem Cat# CBA055); &#x0002a;MSc: Mascot Ion Index; &#x0002a;&#x0002a;&#x00394;cn stands for the difference in the cross-correlation score between the top two candidates peptides for a given input data file.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="s3"><title>Discussion</title><p>The redox modulation of NIH/3T3 cell fate entails translocation of Akt1 to mitochondria. This fact defines Akt1 cellular dynamics in a three compartmental signaling pathway: mitochondria&#x02194;cytosol&#x02194;nucleus, with further effects on the progression of cell cycle or on apoptosis. A redox connection between Akt1 and mitochondria has been formerly revealed by Nogueira <italic>et al</italic>. <xref ref-type="bibr" rid="pone.0007523-Nogueira1">&#x0005b;18&#x0005d;</xref> in MEFs cells where wt myrAkt transfection increased the respiratory rate and promoted high 2&#x02032;,7&#x02032;-dichlorofluorescein-diacetate (DCFH-DA) fluorescence due to high oxidant yield; in this condition, Akt inhibition with antitumoral rapamycin-PEITC association revealed cell switching to apoptosis. It is surmised that irrespective of concentration, Akt uses and drives H<sub>2</sub>O<sub>2</sub> as a single mitochondrial signal to control its final effects on the cell cycle.</p><p>The bases for Akt activation at low H<sub>2</sub>O<sub>2</sub> relied on the efficient sequential biphosphorylation at Ser<sup>473</sup> and Thr<sup>308</sup>. Low redox stimuli thereby acts by increasing the mitochondrial availability of monophosphorylated P-Akt1 Ser<sup>473</sup> which depends on the extramitochondrial activation of mTORC2 by PI3K <xref ref-type="bibr" rid="pone.0007523-Ikenoue1">&#x0005b;8&#x0005d;</xref>. mTORC2 expression is rather poor in mitochondria and therefore Akt1 Ser<sup>473</sup> is mostly phosphorylated outside the organelles. Recently, Alessi <italic>et al</italic>. reported an additional phosphorylation by mTORC2 in Akt Thr<sup>450</sup> in the turn motif that protects the hydrophobic motif from dephosphorylation and increases the stability of P-Akt1 Ser<sup>473</sup><xref ref-type="bibr" rid="pone.0007523-Alessi1">&#x0005b;22&#x0005d;</xref>. mTORC2 activity is therefore associated here to fast P-Akt1 Ser<sup>473</sup> entrance to mitochondria with prompt exit of Akt1 Ser<sup>473</sup>/Thr<sup>308</sup> towards the nucleus. Moreover, unphosphorylated Akt1 cannot enter to isolated mitochondria (<xref ref-type="fig" rid="pone-0007523-g005">Fig. 5</xref>) and, on the contrary; solely P-Akt Ser<sup>473</sup> is easily translocated to the organelles <italic>ex vivo</italic> being found after a few minutes in the supernatant as P-Akt1 Ser<sup>473</sup>/Thr<sup>308</sup> (<xref ref-type="fig" rid="pone-0007523-g005">Fig. 5</xref>). In normal cells, mitochondrial availability of P-Akt Ser<sup>473</sup> is modulated as well by the activity of antitumoral PI3K phosphatase PTEN. It is noticed that PTEN is reversibly inactivated in the NIH cells by 50&#x02013;100 &#x000b5;M H<sub>2</sub>O<sub>2</sub>, through the oxidation of Cys<sup>124</sup><xref ref-type="bibr" rid="pone.0007523-Kwon1">&#x0005b;23&#x0005d;</xref>.</p><p>Under hormone stimulation, a similar kinetics was found by Bijur and Jope who reported rapid insulin-induced translocation of P-Akt Ser<sup>473</sup> to energized mitochondria from SKYH cells; the authors identified several target proteins that underwent Akt-dependent phosphorylation, including GSK-3 &#x003b1;/&#x003b2; and a subunit of ATP synthase <xref ref-type="bibr" rid="pone.0007523-Bijur1">&#x0005b;11&#x0005d;</xref>. Our group reported a similar translocation of Akt1 and Akt2 to muscle mitochondria by long-lasting insulin that ended in the phosphorylation of mitochondrial nitric oxide synthase (mtNOS) and GSK-3 &#x003b1;/&#x003b2;, with significant changes in glucose metabolism <xref ref-type="bibr" rid="pone.0007523-Finocchietto1">&#x0005b;12&#x0005d;</xref>.</p><p>Conversely, high H<sub>2</sub>O<sub>2</sub> concentration resulted in disruption of the second phosphorylation of Akt at Thr<sup>308</sup> in mitochondria and in the consequent accumulation of the monophosphorylated P-Akt1 Ser<sup>473</sup> with very low activity in the organelles. The apoptotic response to high H<sub>2</sub>O<sub>2</sub> is complex and involves both the activation of proapoptotic pathways (release of cyt. <italic>c</italic>, <xref ref-type="fig" rid="pone-0007523-g001">Fig. 1</xref>) and loss of repression of apoptosis (the survival signal) due to Akt1 (activation or inhibition of antiapoptic Bcl-x<sub>L</sub> at the different redox states; <xref ref-type="fig" rid="pone-0007523-g001">Fig. 1</xref>). It may be surmised that the multiplicity of redox mechanisms that trigger mitochondrial apoptosis is centered on the weak inhibitory effects of monophosphorylated Akt in the organelles; at the same H<sub>2</sub>O<sub>2</sub> concentration, the higher percentage of apoptotic cells was achieved at maximal inhibition of PI3K/Akt pathway (<xref ref-type="fig" rid="pone-0007523-g001">Fig. 1</xref>). Therefore, a marked increase of GSK-3 &#x003b1;/&#x003b2; activity due to weak Akt1 activation (<xref ref-type="fig" rid="pone-0007523-g003">Fig. 3</xref>) contributed to NIH/3T3 cell apoptosis (<xref ref-type="fig" rid="pone-0007523-g001">Fig. 1</xref>); proapoptotic GSK3 &#x003b1;/&#x003b2; activity is abolished by phosphorylation at Ser<sup>23</sup> and Ser<sup>9</sup>, mainly catalyzed by Akt in mitochondria <xref ref-type="bibr" rid="pone.0007523-Ohori1">&#x0005b;24&#x0005d;</xref>. Otherwise, prevention of staurosporin-induced apoptosis by Akt1 is a protective mechanism that involves the activation of Bcl-x<sub>L</sub> and reciprocally, this protein promotes or restores the Akt1 activity <xref ref-type="bibr" rid="pone.0007523-Wang1">&#x0005b;25&#x0005d;</xref>. The antitumoral effects of rapamycin are due to the disruption of Akt and the decline of Bcl-x<sub>L</sub>. Inhibition of mTOR-p70S6 pathway and Akt1 by rapamycin dramatically inhibits transformation of NIH/3T3 cells in over-expressing constitutively active myr-Akt1 (3T3-Akt1 cells) or myr-Akt2 <xref ref-type="bibr" rid="pone.0007523-Liu1">&#x0005b;3T3&#x02013;Akt2 cells, 26&#x0005d;</xref>.</p><p>The second phosphorylation of Thr<sup>308</sup> is required for sustaining a significant traffic of mitochondrial Akt to nucleus. Mutant Akt T308A is rather limited in its entrance to nucleus and the precursor P-Akt1 Ser<sup>473</sup> accumulates in mitochondria, thus mimicking the effects of high H<sub>2</sub>O<sub>2</sub> concentration. Phosphorylation at Thr<sup>308</sup> is PDK1-dependent <xref ref-type="bibr" rid="pone.0007523-Toker1">&#x0005b;27&#x0005d;</xref> and completes the initial effect of mTORC2. The sequential phosphorylation of Ser<sup>473</sup> and Thr<sup>308</sup> has been previously reported <italic>in vivo</italic><xref ref-type="bibr" rid="pone.0007523-Sarbassov1">&#x0005b;6&#x0005d;</xref>; disruption of PDK1 reduces phosphorylation of Thr<sup>308</sup><italic>in vivo</italic>, and PDK1 deficient mice are considerably smaller than wt animals <xref ref-type="bibr" rid="pone.0007523-Bayascas1">&#x0005b;28&#x0005d;</xref>. We demonstrate here that PDK1 binds P-Akt1 Ser<sup>473</sup> at the mitochondrial outer membrane and the intermembrane space and that PDK1 is constitutively active (P-PDK1) at this localization. Previous studies in NIH cells propose that PDK1 is permanently complexed to Akt at the PH domain in an inactive conformational state that might be turned into an active state by growth factors or, hypothetically, by redox status <xref ref-type="bibr" rid="pone.0007523-Calleja1">&#x0005b;29&#x0005d;</xref>. In addition and guided by the Peckstrin homology domains, Akt1 and PDK migrate to plasma membrane where PDK1 activity is markedly increased by PtdIns; Filippa <italic>et al</italic>. showed that it is P-PDK-1 that recruits Akt1 to the plasma membrane <xref ref-type="bibr" rid="pone.0007523-Filippa1">&#x0005b;30&#x0005d;</xref>. Interestingly, Connor et al. demonstrated that the mitochondrial membrane contains PtdIns as well and that alterations in the steady-state production of mitochondrial H<sub>2</sub>O<sub>2</sub> modulate the redox state of PTEN <xref ref-type="bibr" rid="pone.0007523-Connor1">&#x0005b;31&#x0005d;</xref>. The alternative amount of Akt1 or Akt-PDK1 migrating to mitochondrial or plasma membranes should depend on the stimuli (H<sub>2</sub>O<sub>2</sub> produced in mitochondria or growth factors acting on plasma membrane TK receptors) and, under certain circumstances, Akt and PDK1 complex could be partitioned into the two membranes for cooperative effects. However in this work, membrane preparations obtained from NIH/3T3 cells and devoided of mitochondria contained P-PDK-1 but were unable to efficiently phosphorylate Akt1 Thr<sup>308</sup> (<xref ref-type="fig" rid="pone-0007523-g006">Fig. 6</xref>).</p><p>The modulation of Akt1 binding to PDK1 depended on specific thiol oxidations (<xref ref-type="table" rid="pone-0007523-t001">Table 1</xref>). In non-stimulated cells Akt1 Cys<sup>310</sup> adjacent to Thr<sup>308</sup> in the catalytic loop was basally oxidized to sulfenic acid (-SO<sup>&#x02212;</sup>), a modification also observed at very low H<sub>2</sub>O<sub>2</sub> concentration. In this context, we hypothesized that a disulfide bridge may stabilize Akt1-PDK1 binding thus favoring Thr<sup>308</sup> phosphorylation at the very low H<sub>2</sub>O<sub>2</sub> concentration. Otherwise, as it occurs in peroxiredoxins, an ATP reaction with Cys-SO<sup>-</sup> may form a phosphoryl thiol that may finally transfer the phosphate to Thr<sup>308</sup><xref ref-type="bibr" rid="pone.0007523-Aran1">&#x0005b;32&#x0005d;</xref>. Instead, moderate to high H<sub>2</sub>O<sub>2</sub> concentration led to strong oxidation of Akt1 Cys<sup>60</sup> in the PH domain, and Akt1 Cys<sup>310</sup> to sulfonic acid (-SO<sub>3</sub><sup>2&#x02212;</sup>). In this case, negative charges likewise disrupt the PDK1 approach to the Akt1 Pleckstrin homology domain, and the advance of negatively charged ATP<sup>3&#x02212;</sup> to Thr<sup>308</sup>. In accord, C310A mutation in Akt inhibits its catalytic activity, an effect also obtained by supplementation with lactoquinomycin which acts on the Cys<sup>310</sup>&#x02013;S<sup>&#x02212;</sup> group <xref ref-type="bibr" rid="pone.0007523-ToralBarza1">&#x0005b;33&#x0005d;</xref> Comparatively, ERK2 is as well oxidized at Cys<sup>38</sup> and Cys<sup>214</sup> to get an efficient binding with its upstream kinases MEK1/2 in mitochondria <xref ref-type="bibr" rid="pone.0007523-Galli2">&#x0005b;34&#x0005d;</xref>.</p><p>Mitochondrial contribution to proliferation and apoptosis has been revealed in the last decade. As shown here, redox modulation of cell fate involved Akt intramitochondrial signaling. This contribution is understood on the bases that a) mitochondria are the most important oxygen users and producers of oxidants like H<sub>2</sub>O<sub>2</sub>; b) double phosphorylation of kinases may represent a cooperative control of activation in redox modulation of metabolism.</p><p>It may be surmised that, Akt phosphorylation in mitochondria is not only a single step in kinase activation, but a modality in which cells select predominantly mitochondrial apoptotic or nuclear proliferative pathways (<xref ref-type="fig" rid="pone-0007523-g006">Fig. 6B</xref>). We reported that mitochondrial dysfunction is associated to low H<sub>2</sub>O<sub>2</sub> yield and persistent proliferation in embryonic and transformed cells <xref ref-type="bibr" rid="pone.0007523-Galli2">&#x0005b;34&#x0005d;</xref>. These effects imply that the disruption of intramitochondrial signaling in the activation of kinases might conduct to persistent proliferation and cancer or to premature cell death.</p></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec id="s4a"><title>Cell line, culture conditions and treatments</title><p>NIH/3T3 cell line was maintained in Dulbecco's modified Eagle's medium (D-MEM, Gibco) supplemented with 10&#x00025; bovine calf serum (BCS) and 50 &#x000b5;g/ml gentamycin at 37&#x000b0;C in a humidified 5&#x00025; CO<sub>2</sub> atmosphere. For treatment, cells were 24 h serum starved, and then stimulated with H<sub>2</sub>O<sub>2</sub> and/or the Akt inhibitor (LY294002, Sigma) at the appropriate concentrations.</p></sec><sec id="s4b"><title>Preparation of nuclear, mitochondrial and cytosolic fractions</title><p>NIH/3T3 cells were lysed in MSHE buffer (0.22 M mannitol, 0.07 M sucrose, 0.5 mM EGTA, 2 mM HEPES/KOH, 1 mM phenylmethylsulfonylfluoride (PMSF), 5 &#x000b5;g/ml leupeptin, 5 &#x000b5;g/ml pepstatin, 5 &#x000b5;g/ml aprotinin, 25 mM NaF, 1 mM sodium orthovanadate, pH 7.4. The homogenate was centrifuged for 10 min at 1000&#x000d7;<italic>g</italic> (pellet&#x0200a;&#x0003d;&#x0200a; crude nuclear extract). The supernatant was centrifuged at 10000&#x000d7;<italic>g</italic> for 20 min; supernatant fraction (cytosol) was then collected and mitochondrial pellet fraction was resuspended in MSHE. The crude nuclear pellet was washed once with buffer A (10 mM Tris, 1.5 mM EDTA, 10&#x00025; glycerol, 1 mM PMSF, 5 &#x000b5;g/ml leupeptin, 5 &#x000b5;g/ml pepstatin, 5 &#x000b5;g/ml aprotinin, 5 mM NaF, 1 mM sodium orthovanadate, pH 7.4) containing NP-40 0.01&#x00025;. The washed crude nuclear pellet was then resuspended in buffer A plus 0.4 M KCl, and incubated for 30 min at 4&#x000b0;C. The suspension was centrifuged at 15000&#x000d7;<italic>g</italic> (30 min) and diluted with the same volume of buffer A to reduce salt concentration <xref ref-type="bibr" rid="pone.0007523-ToralBarza1">&#x0005b;33&#x0005d;</xref>. The purity of the fractions was assessed by Western blot with antibodies against complex I (mitochondria), &#x003b2;-actin (cytosol) and RNA POL II (subunit 250 kDa) (nuclei). Protein concentration was determined by Bradford method <xref ref-type="bibr" rid="pone.0007523-Bradford1">&#x0005b;35&#x0005d;</xref>.</p></sec><sec id="s4c"><title>Submitochondrial fractioning</title><p>Purified mitochondria were osmotically broken by diluting the mitochondrial pellet in four volumes of distilled water and centrifuged for 10 min at 12000&#x000d7;<italic>g</italic> to give a supernatant containing the mitochondrial outer membrane and the intermembrane space, and a mitoplast pellet (inner membrane enclosing the matrix). Then, the mitoplast fraction was sonicated twice at 40 W for 10 sec with a Cole-Parmer sonicator (WPI, Sarasota, FL, USA). Subsequently, samples were centrifuged for 10 min at 8000&#x000d7;<italic>g</italic> to precipitate unbroken mitochondria. This supernatant, together with the first step one, were centrifuged for 30 min at 100000&#x000d7;<italic>g</italic> obtaining inner membrane and matrix, and outer membrane with intermembrane space, in the pellet and supernatant of both fractions respectively <xref ref-type="bibr" rid="pone.0007523-Alonso1">&#x0005b;36&#x0005d;</xref>.</p></sec><sec id="s4d"><title>Proliferation assay</title><p>NIH/3T3 cells were seeded in a multiwell plate, serum starved for 24 h, and treated with H<sub>2</sub>O<sub>2</sub> for another 48 h in the presence of 0.8 &#x000b5;Ci/well of &#x0005b;<sup>3</sup>H&#x0005d; thymidine (specific activity, 70 to 90 Ci/mmol; NEN/Dupont, Boston, Mass.). Cells were then trypsinized and harvested. Assays were performed in octuplicate. Radioactivity was measured in a liquid scintillation counter (Wallac 1414, Turku, Finland, 33).</p></sec><sec id="s4e"><title>Apoptosis assays</title><p>NIH/3T3 cells treated with H<sub>2</sub>O<sub>2</sub>, were harvested and incubated with (i) 100 mg/ml propidium iodide in 0.1&#x00025; sodium citrate, 0.1&#x00025; Triton X-100 at 4&#x000b0;C overnight in the darkness <xref ref-type="bibr" rid="pone.0007523-Nicoletti1">&#x0005b;37&#x0005d;</xref> or (ii) Annexin V-FITC (Immunotech) according to manufacturer's instructions. Cells were run on a FACScalibur flow cytometer (Becton-Dickinson, Mountain View, CA) and analyzed with WinMDI software for Windows.</p></sec><sec id="s4f"><title>Western blot</title><p>Mitochondrial, nuclear (50 &#x000b5;g/lane each) and cytosolic proteins (25 &#x000b5;g/lane) were separated by electrophoresis on SDS-polyacrylamide gels and transferred to a PVDF membrane (GE Healthcare). Membranes were incubated with antibodies anti Akt1, P-Akt1 Ser<sup>473</sup>, P-Akt1 Thr<sup>308</sup> (Cell Signaling), cytochrome <italic>c</italic>, complex I, His (Molecular Probes), Bcl-x<sub>L</sub>, cyclin D1, &#x003b2;-actin, RNA POL RPB6 (Santa Cruz) or caspase 3 and HA (Sigma). Secondary antibodies were conjugated to horseradish peroxidase (GE Healthcare). Detection of immunoreactive proteins was accomplished by chemiluminescence with ECL (GE Healthcare). Quantification of bands was performed by digital image analysis using a Hewlett-Packard Scanner and Totallab analyzer software (Nonlinear Dynamics Ltd, Biodynamics, Argentina). For Li-Cor detection system, membranes were incubated with goat anti-rabbit IRDye 800CW and goat anti-mouse IRDye 680 (Li-Cor Biosciences) and fluorescence was detected using the Oddysey Infrared Imaging System (Li-Cor Biosciences).</p></sec><sec id="s4g"><title>Akt activity assay</title><p>Mitochondria were lysed in 50 mM Tris HCl pH 7.4, 0.1 mM EDTA, 0.1 mM EGTA and immunoprecipitation was carried out using an immobilized Akt1 antibody. After centrifugation, the pellet was washed twice in PBS and resuspended in kinase buffer (50 mM Hepes K<sup>&#x0002b;</sup> pH 7.5, 150 mM NaCl, 1 mM EDTA, 2.5 mM EGTA, 50 mM NaF, 0.183 mg/ml sodium orthovanadate, 1 mM DTT and 0.1&#x00025; Tween 20) supplemented with 1 &#x000b5;l of 10 mM ATP and 1 &#x000b5;g of GSK-3 fusion protein. The mix was incubated for 30 min. at 30&#x000b0;C and the reaction was finished with 25 &#x000b5;l 3x sample buffer. Finally, samples were run on SDS-PAGE and transferred to PVDF membranes. Membranes were incubated with a P-GSK-3 &#x003b1;/&#x003b2; antibody (Cell Signaling) and revealed as previously described.</p></sec><sec id="s4h"><title>Pull down assay</title><p>Mitochondrial fractions were incubated in the presence of human recombinant Akt1-GST agarose (Cell Signaling) in lysing buffer for 2 h at 4&#x000b0;C. When appropriate, recombinant kinase was oxidized with H<sub>2</sub>O<sub>2</sub>. After incubation, agarose beads were precipitated, washed in lysing buffer and cracked in Laemmli-loading buffer. Finally, samples were analyzed by western blot as described above incubated with an antibody anti PDK1 (Cell Signaling) and revealed as previously mentioned.</p></sec><sec id="s4i"><title>Transient transfections</title><p>Cells were seeded onto a 22.1 -mm diameter well and transiently transfected with 1 &#x000b5;g of pcDNA3 wild type Akt1, Akt1 S473A or Akt1 T308A (obtained by <italic>in vitro</italic> site-directed mutagenesis system, Promega). Transfections were carried out for 24 h in DMEM with 10&#x00025; BCS without antibiotics utilizing Lipofectamine Reagent in Opti-MEM (Invitrogen). After transfection, cells were stimulated with 50 &#x000b5;M H<sub>2</sub>O<sub>2</sub> for the indicated times before cells were harvested and prepared for subcellular fractionation. Samples were analyzed by western blot as above with an anti-HA antibody (Sigma).</p></sec><sec id="s4j"><title>Phosphorylation and translocation assay</title><p>0.3 &#x000b5;g of recombinant inactive Akt1 (Prospec) and 0.8 &#x000b5;g of mTOR (Calbiochem) were incubated in kinase buffer (Calbiochem), supplemented with 20 mM ATP and 100 mM DTT for 30 min. at 30&#x000b0;C to allow for phosphorylation. Purified mitochondria were co-incubated with the phosphorylation mixture in import buffer (250 mM sacarose, 10 mM MOPS, 5 mM MgCl<sub>2</sub>, 80 mM KCl and 2.5 mM KPi, pH 7.2) supplemented with 2 mM ATP, 2 mM NADH and 20 mM succinate at 25&#x000b0;C. The reaction was finished by the addition of 25 &#x000b5;M FCCP for 10 min. at 4&#x000b0;C. The samples were centrifuged at 10000&#x000d7;<italic>g</italic> for 20 min. and the pellet and supernatant were prepared for SDS-PAGE.</p></sec><sec id="s4k"><title>Membrane vesicles purification</title><p>NIH/3T3 cells were lysed in MSHE buffer as described above. The homogenate was centrifuged for 10 min at 1000&#x000d7;<italic>g</italic>; mitoplasts were isolated from the supernatant and the pellet was resuspended in isolation buffer (250 mM sucrose, 5 mM K-Hepes, 1 mM EGTA, pH 7.4). The suspension was passed four times through a tight fitting pestle and plasma membrane vesicles were purified from a Percoll (GE Healthcare) gradient by ultracentrifugation <xref ref-type="bibr" rid="pone.0007523-Cefaratti1">&#x0005b;38&#x0005d;</xref>.</p></sec><sec id="s4l"><title>Plasma membrane vesicles and mitoplasts incubation</title><p>Plasma membrane fraction and mitoplasts (labelled with MitoTracker Deep Red) were incubated in a 100 &#x000b5;l final volume mix (import buffer). The suspension was co-incubated with 0.3 &#x000b5;g recombinant inactive Akt1 (Prospec), 20 mM ATP and 100 mM MgCl<sub>2</sub> for 30 min. at 30&#x000b0;C. The mixture was centrifuged at 10000&#x000d7;<italic>g</italic> for 20 min. The pellet was resuspended in 50 mM Tris (plus 0.3&#x00025; Triton X-100 and 1&#x00025; BSA).</p></sec><sec id="s4m"><title>Fluorescence labeling</title><p>Cells were grown on Lab-Tek Chambered Borosilicate Coverglass System (Nunc) for <italic>in vivo</italic> experiments and transfected with wild type Akt1-GFP or its mutants, Akt1 T308A-GFP or Akt1 S473A-GFP using Lipofectamine 2000 (Invitrogen). Cells were stained with MitoTracker Deep Red (Invitrogen, 100 nM, 45 min at 37&#x000b0;C). At the moment of image acquisition, cells were stimulated with 50 &#x000b5;M H<sub>2</sub>O<sub>2</sub>. For the phosphorylation assay, mitoplasts stained with 5 &#x000b5;M Mitotracker Deep Red (1 h at 37&#x000b0;C) and vesicles were incubated together with 0.3 &#x000b5;g Akt1 in an import assay (30 min at 37&#x000b0;C). The preparations were washed, fixed in 4&#x00025; paraformaldehyde and resuspended in 50 mM Tris, 0.3&#x00025; Triton X-100, 1&#x00025; BSA and co-incubated with primary antiobodies (P-Thr<sup>308</sup>or P-Ser<sup>473</sup> and ATPase) and secondary antibodies (anti-rabbit Cy2 linked or anti-mouse Cy3 linked). For washing, samples were centrifuged at 10000&#x000d7;<italic>g</italic> for 20 min. Finally, samples were resuspended in PBS and mounted onto coverslides with Fluorsave (Calbiochem).</p></sec><sec id="s4n"><title>Confocal microscopy and image analysis</title><p>Images were acquired in an Olympus FV1000 confocal laser scanning microscope with a 60&#x000d7;1.35 NA oil immersion objective. Excitation and filters were as follows: GFP and Cy2, 488 nm excitation, emission BP 500&#x02013;530 nm; Cy3, 543 nm excitation, emission BP 555&#x02013;655 nm, MitoTracker Deep Red, 633 nm excitation, emission BP 655&#x02013;755 nm. Images were acquired in a sequential mode. No channel cross-talk was recovered in any case. The image and statistical analysis was performed with Matlab (MathWorks, Natick, MA) and DIPimage (image processing toolbox for Matlab, Delft University of Technology, The Netherlands). For image analysis, see <xref ref-type="supplementary-material" rid="pone.0007523.s011">Methods S5</xref>.</p></sec><sec id="s4o"><title>Mass spect</title><p>The Akt protein band was excised from a 1D coomassie stained gel and subjected to in-gel tryptic digestion as previously reported <xref ref-type="bibr" rid="pone.0007523-Shevchenko1">&#x0005b;39&#x0005d;</xref>. The digest was done in the presence of a mass spectrometry friendly surfactant to provide increased sequence coverage (Protease Max, Promega, Wisconsin) and the reduction steps using DTT was excluded. Samples were alkylated with 10 &#x000b5;M acrylamide (&#x0002b;71 Da) at room temperature for 30 minutes. Extracted peptides were dried to completion and reconstituted to 8 &#x000b5;l in 0.1&#x00025; formic acid, 2&#x00025; acetonitrile, 97.9&#x00025; water. The mass spectrometer was a LCQ Deca XP Plus (Thermo Scientific) which was set in data dependent acquisition mode to perform MS/MS on the top three most intense ions with a dynamic exclusion setting of two (<xref ref-type="supplementary-material" rid="pone.0007523.s012">Methods S6</xref>).</p></sec><sec id="s4p"><title>Statistical analysis</title><p>Data are expressed as means &#x000b1; SE and analysed by one-way analysis of variance (ANOVA), Dunnett's test and Scheff&#x000e9; test. Statistical significance was accepted at <italic>p</italic> &#x0003c;0.05.</p></sec></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0007523.s001"><label>Figure S1</label><caption><p>High redox status drives cells to apoptosis. Apoptosis was determined by acridine orange and ethidium bromide double staining 48 h after H<sub>2</sub>O<sub>2</sub> treatment. Morphology and staining were evaluated in a fluorescence microscope (40x).</p><p>(1.34 MB TIF)</p></caption><media xlink:href="pone.0007523.s001.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0007523.s002"><label>Figure S2</label><caption><p>Loss of mitochondrial membrane potential is involved in H<sub>2</sub>O<sub>2</sub>-triggered apoptosis. The dynamic of the loss of the mitochondrial membrane potential was monitored by the potential-sensitive dye Rho123 under flow cytometry by duplicate in H<sub>2</sub>O<sub>2</sub> treated and control cells.</p><p>(0.38 MB TIF)</p></caption><media xlink:href="pone.0007523.s002.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0007523.s003"><label>Figure S3</label><caption><p>Purity controls of the different subcellular fractions by duplicate using specific antibodies against complex I (mitochondria), &#x003b2;-actin (cytosol) and RNA POL II (subunit 250 kDa) (nuclei).</p><p>(0.36 MB TIF)</p></caption><media xlink:href="pone.0007523.s003.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0007523.s004"><label>Figure S4</label><caption><p>Presence and translocation of hAkt1 and its phosphorylation mutants Akt1 S473A and Akt1 T308A into mitochondria. NIH/3T3 cells transfected with Akt1-GFP, Akt1 S473A-GFP and Akt1 T308A-GFP and stained with MitoTracker Deep Red were stimulated 50 &#x000b5;M H<sub>2</sub>O<sub>2</sub>. Fluorescence intensity of both green (GFP) and red (Mitotracker) channels was followed for 20 min in an Olympus FV1000 confocal microscope. (A) Series of representative merged images after H<sub>2</sub>O<sub>2</sub> stimulation for Akt and its phosphorylation mutants are shown. An image corresponding to the mitochondrial mask determined by a colocalization algorithm for each image pair is shown on the right. Bar &#x0200a;&#x0003d;&#x0200a;10 &#x000b5;m. (B) Nuclear and cellular masks in which GFP fluorescence change was followed after H<sub>2</sub>O<sub>2</sub> stimulation (see methods).</p><p>(1.99 MB TIF)</p></caption><media xlink:href="pone.0007523.s004.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0007523.s005"><label>Table S1</label><caption><p>Mitochondrial membrane potential (&#x00394;&#x003c8;mit) was determined by duplicate by measuring Rhodamine 123 fluorescence at 503 nm with a Hitachi F-3010 spectrofluorometer at 37&#x000b0;C. NIH/3T3 mitochondria (0.2 mg/ml) were added to the media and the fluorescence of the suspension was measured. The initial total amount of Rh-123 in the cuvette (&#x0005b;Rh-123&#x0005d;total) and the amount remaining in the media (&#x0005b;Rh-123&#x0005d; out) were used to calculate by subtraction the total amount of Rh-123 taken up by mitochondria (&#x0005b;Rh-123&#x0005d;mit, in nmol/mg protein). Mitochondrial membrane potentials (negative inside) were calculated by the electrochemical Nernst-Guggenheim equation: &#x00394;&#x003c8;mit&#x0200a;&#x0003d;&#x0200a;59 log (&#x0005b;Rh-123&#x0005d;in/&#x0005b;Rh-123&#x0005d;out). Additions: 8 mM malate (mal); 8 mM glutamate (glu).</p><p>(0.03 MB DOC)</p></caption><media xlink:href="pone.0007523.s005.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0007523.s006"><label>Table S2</label><caption><p>Complex IV activity was determined by duplicate by recording the oxidation of reducedcytochrome c at 550 nm in the different NIH/3T3 subcellular fractions. Lactate dehydrogenase activity was monitored spectrophotometrically by duplicate in NIH/3T3 subcellular fractions through oxidation of NADH at 340 nm.</p><p>(0.03 MB DOC)</p></caption><media xlink:href="pone.0007523.s006.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0007523.s007"><label>Methods S1</label><caption><p>(0.02 MB DOC)</p></caption><media xlink:href="pone.0007523.s007.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0007523.s008"><label>Methods S2</label><caption><p>(0.03 MB DOC)</p></caption><media xlink:href="pone.0007523.s008.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0007523.s009"><label>Methods S3</label><caption><p>(0.03 MB DOC)</p></caption><media xlink:href="pone.0007523.s009.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0007523.s010"><label>Methods S4</label><caption><p>(0.03 MB DOC)</p></caption><media xlink:href="pone.0007523.s010.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0007523.s011"><label>Methods S5</label><caption><p>(0.03 MB DOC)</p></caption><media xlink:href="pone.0007523.s011.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0007523.s012"><label>Methods S6</label><caption><p>(0.02 MB DOC)</p></caption><media xlink:href="pone.0007523.s012.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0007523.s013"><label>Video S1</label><caption><p>NIH/3T3 cells transfected with Akt1 T308A-GFP and stained with MitoTracker Deep Red were stimulated 50 &#x000b5;M H<sub>2</sub>O<sub>2</sub>. Fluorescence intensity of both green (GFP) and red (Mitotracker) channels was followed for 20 min in an Olympus FV1000 confocal microscope.</p><p>(1.34 MB AVI)</p></caption><media xlink:href="pone.0007523.s013.avi" mimetype="video" mime-subtype="x-msvideo"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0007523.s014"><label>Video S2</label><caption><p>Same as <xref ref-type="supplementary-material" rid="pone.0007523.s013">Video S1</xref> but redistribution kinetics was followed in a zoomed image as in <xref ref-type="fig" rid="pone-0007523-g004">Fig. 4D</xref>.</p><p>(0.33 MB AVI)</p></caption><media xlink:href="pone.0007523.s014.avi" mimetype="video" mime-subtype="x-msvideo"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0007523.s015"><label>Video S3</label><caption><p>NIH/3T3 cells transfected with Akt1 T308A-GFP and stained with MitoTracker Deep Red were stimulated 50 &#x000b5;M H<sub>2</sub>O<sub>2</sub>. Fluorescence intensity of both green (GFP) and red (Mitotracker) channels was followed for 20 min in an Olympus FV1000 confocal microscope.</p><p>(1.16 MB AVI)</p></caption><media xlink:href="pone.0007523.s015.avi" mimetype="video" mime-subtype="x-msvideo"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0007523.s016"><label>Video S4</label><caption><p>Same as <xref ref-type="supplementary-material" rid="pone.0007523.s015">Video S3</xref> but redistribution kinetics was followed in a zoomed image as in <xref ref-type="fig" rid="pone-0007523-g004">Fig. 4D</xref>.</p><p>(0.31 MB AVI)</p></caption><media xlink:href="pone.0007523.s016.avi" mimetype="video" mime-subtype="x-msvideo"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank Dr. Natalia Riob&#x000f3;, Thomas Jefferson University, Philadelphia, Pennsylvania, USA, for the kind gift of Akt1 vectors. We are grateful to Dr. Jean Paul Rossi, Faculty of Pharmacy and Biochemistry, University of Buenos Aires, Argentina for the antibody anti ATPase.</p></ack><ref-list><title>References</title><ref id="pone.0007523-Brazil1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brazil</surname><given-names>DP</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Hemmings</surname><given-names>BA</given-names></name></person-group><year>2002</year><article-title>PKB Binding Proteins: Getting in on the Akt.</article-title><source>Cell</source><volume>111</volume><fpage>293</fpage><lpage>303</lpage><pub-id pub-id-type="pmid">12419241</pub-id></mixed-citation></ref><ref id="pone.0007523-Bellacosa1"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellacosa</surname><given-names>A</given-names></name><name><surname>Testa</surname><given-names>JR</given-names></name><name><surname>Staal</surname><given-names>SP</given-names></name><name><surname>Tsichlis</surname><given-names>PN</given-names></name></person-group><year>1991</year><article-title>A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region.</article-title><source>Science</source><volume>254</volume><fpage>274</fpage><lpage>277</lpage><pub-id pub-id-type="pmid">1833819</pub-id></mixed-citation></ref><ref id="pone.0007523-Staal1"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staal</surname><given-names>SP</given-names></name></person-group><year>1987</year><article-title>Molecular cloning of the Akt oncogene and its human homologues Akt1 and Akt2: amplification of Akt1 in a primary human gastric adenocarcinoma.</article-title><source>Proc Natl Acad Sci U S A</source><volume>84</volume><fpage>5034</fpage><lpage>5037</lpage><pub-id pub-id-type="pmid">3037531</pub-id></mixed-citation></ref><ref id="pone.0007523-Bellacosa2"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellacosa</surname><given-names>A</given-names></name><name><surname>Franke</surname><given-names>TF</given-names></name><name><surname>Gonzalez-Portal</surname><given-names>ME</given-names></name><name><surname>Datta</surname><given-names>K</given-names></name><name><surname>Taguichi</surname><given-names>T</given-names></name><etal/></person-group><year>1993</year><article-title>Structure, expression and chromosomal mapping of c-akt: Relationship to v-akt and its implications.</article-title><source>Oncogene</source><volume>8</volume><fpage>745</fpage><lpage>754</lpage><pub-id pub-id-type="pmid">8437858</pub-id></mixed-citation></ref><ref id="pone.0007523-Franke1"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franke</surname><given-names>TF</given-names></name><name><surname>Yang</surname><given-names>SI</given-names></name><name><surname>Chan</surname><given-names>TO</given-names></name><name><surname>Datta</surname><given-names>K</given-names></name><name><surname>Kazlauskas</surname><given-names>A</given-names></name><etal/></person-group><year>1995</year><article-title>The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase.</article-title><source>Cell</source><volume>2</volume><fpage>727</fpage><lpage>736</lpage><pub-id pub-id-type="pmid">7774014</pub-id></mixed-citation></ref><ref id="pone.0007523-Sarbassov1"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarbassov</surname><given-names>DD</given-names></name><name><surname>Guertin</surname><given-names>DA</given-names></name><name><surname>Ali</surname><given-names>SM</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name></person-group><year>2005</year><article-title>Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.</article-title><source>Science</source><volume>18</volume><fpage>1098</fpage><lpage>1101</lpage><pub-id pub-id-type="pmid">15718470</pub-id></mixed-citation></ref><ref id="pone.0007523-Jacinto1"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacinto</surname><given-names>E</given-names></name><name><surname>Facchinetti</surname><given-names>V</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Soto</surname><given-names>N</given-names></name><name><surname>Wei</surname><given-names>S</given-names></name><etal/></person-group><year>2006</year><article-title>SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity.</article-title><source>Cell</source><volume>127</volume><fpage>125</fpage><lpage>137</lpage><pub-id pub-id-type="pmid">16962653</pub-id></mixed-citation></ref><ref id="pone.0007523-Ikenoue1"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikenoue</surname><given-names>T</given-names></name><name><surname>Inoki</surname><given-names>K</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Guan</surname><given-names>KL</given-names></name></person-group><year>2008</year><article-title>Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling.</article-title><source>EMBO J</source><volume>23</volume><fpage>1919</fpage><lpage>1931</lpage><pub-id pub-id-type="pmid">18566587</pub-id></mixed-citation></ref><ref id="pone.0007523-Chan1"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>TO</given-names></name><name><surname>Rittenhouse</surname><given-names>SE</given-names></name><name><surname>Tsichlis</surname><given-names>PN</given-names></name></person-group><year>1999</year><article-title>AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation.</article-title><source>Annu Rev Biochem</source><volume>68</volume><fpage>965</fpage><lpage>1014</lpage><pub-id pub-id-type="pmid">10872470</pub-id></mixed-citation></ref><ref id="pone.0007523-Frdin1"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fr&#x000f6;din</surname><given-names>M</given-names></name><name><surname>Antal</surname><given-names>TL</given-names></name><name><surname>D&#x000fc;mmler</surname><given-names>BA</given-names></name><name><surname>Jensen</surname><given-names>CJ</given-names></name><name><surname>Deak</surname><given-names>M</given-names></name><etal/></person-group><year>2002</year><article-title>A phosphoserine/threonine-binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation.</article-title><source>EMBO J</source><volume>21</volume><fpage>5396</fpage><lpage>5407</lpage><pub-id pub-id-type="pmid">12374740</pub-id></mixed-citation></ref><ref id="pone.0007523-Bijur1"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bijur</surname><given-names>GN</given-names></name><name><surname>Jope</surname><given-names>RS</given-names></name></person-group><year>2003</year><article-title>Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation.</article-title><source>J Neurochem</source><volume>87</volume><fpage>1427</fpage><lpage>1435</lpage><pub-id pub-id-type="pmid">14713298</pub-id></mixed-citation></ref><ref id="pone.0007523-Finocchietto1"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finocchietto</surname><given-names>P</given-names></name><name><surname>Barreyro</surname><given-names>F</given-names></name><name><surname>Holod</surname><given-names>S</given-names></name><name><surname>Peralta</surname><given-names>J</given-names></name><name><surname>Franco</surname><given-names>MC</given-names></name><etal/></person-group><year>2008</year><article-title>Control of muscle mitochondria by insulin entails activation of Akt2-mtNOS pathway: implications for the metabolic syndrome.</article-title><source>PLoS ONE</source><volume>3</volume><fpage>e1749</fpage><pub-id pub-id-type="pmid">18335029</pub-id></mixed-citation></ref><ref id="pone.0007523-Carreras1"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carreras</surname><given-names>MC</given-names></name><name><surname>Franco</surname><given-names>MC</given-names></name><name><surname>Peralta</surname><given-names>JG</given-names></name><name><surname>Poderoso</surname><given-names>JJ</given-names></name></person-group><year>2004</year><article-title>Nitric oxide, complex I, and the modulation of mitochondrial reactive species in biology and disease.</article-title><source>Mol Aspects Med</source><volume>25</volume><fpage>125</fpage><lpage>139</lpage><pub-id pub-id-type="pmid">15051322</pub-id></mixed-citation></ref><ref id="pone.0007523-Carreras2"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carreras</surname><given-names>MC</given-names></name><name><surname>Poderoso</surname><given-names>JJ</given-names></name></person-group><year>2007</year><article-title>Mitochondrial nitric oxide in the signaling of cell integrated responses.</article-title><source>Am J Physiol Cell Physiol</source><volume>292</volume><fpage>C1569</fpage><lpage>1580</lpage><pub-id pub-id-type="pmid">17496232</pub-id></mixed-citation></ref><ref id="pone.0007523-Green1"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>DR</given-names></name><name><surname>Reed</surname><given-names>JC</given-names></name></person-group><year>1998</year><article-title>Mitochondria and apoptosis.</article-title><source>Science</source><volume>281</volume><fpage>1309</fpage><lpage>1312</lpage><pub-id pub-id-type="pmid">9721092</pub-id></mixed-citation></ref><ref id="pone.0007523-Robey1"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robey</surname><given-names>RB</given-names></name><name><surname>Hay</surname><given-names>N</given-names></name></person-group><year>2005</year><article-title>Is Akt the &#x0201c;Warburg kinase&#x0201d;?&#x02015;Akt-energy metabolism interactions and oncogenesis.</article-title><source>Seminars in Cancer Biology</source><volume>19</volume><fpage>25</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">19130886</pub-id></mixed-citation></ref><ref id="pone.0007523-VanderHelden1"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vander Helden</surname><given-names>MG</given-names></name><name><surname>Cantley</surname><given-names>LC</given-names></name><name><surname>Thompson</surname><given-names>CB</given-names></name></person-group><year>2009</year><article-title>Understanding the Warburg effect: the metabolic requirements of cell proliferation.</article-title><source>Science</source><volume>324</volume><fpage>1029</fpage><lpage>1033</lpage><pub-id pub-id-type="pmid">19460998</pub-id></mixed-citation></ref><ref id="pone.0007523-Nogueira1"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nogueira</surname><given-names>V</given-names></name><name><surname>Park</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>CC</given-names></name><name><surname>Xu</surname><given-names>PZ</given-names></name><name><surname>Chen</surname><given-names>ML</given-names></name><etal/></person-group><year>2008</year><article-title>Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis.</article-title><source>Cancer Cell</source><volume>14</volume><fpage>458</fpage><lpage>470</lpage><pub-id pub-id-type="pmid">19061837</pub-id></mixed-citation></ref><ref id="pone.0007523-Galli1"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galli</surname><given-names>S</given-names></name><name><surname>Labato</surname><given-names>MI</given-names></name><name><surname>Bal de Kier Joff&#x000e9;</surname><given-names>E</given-names></name><name><surname>Carreras</surname><given-names>MC</given-names></name><name><surname>Poderoso</surname><given-names>JJ</given-names></name></person-group><year>2003</year><article-title>Decreased mitochondrial nitric oxide synthase activity and hydrogen peroxide relate persistent tumoral proliferation to embryonic behavior.</article-title><source>Cancer Res</source><volume>63</volume><fpage>6370</fpage><lpage>6377</lpage><pub-id pub-id-type="pmid">14559826</pub-id></mixed-citation></ref><ref id="pone.0007523-Cory1"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cory</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>DC</given-names></name><name><surname>Adams</surname><given-names>JM</given-names></name></person-group><year>2003</year><article-title>The Bcl-2 family: roles in cell survival and oncogenesis.</article-title><source>Oncogene</source><volume>22</volume><fpage>8590</fpage><lpage>8607</lpage><pub-id pub-id-type="pmid">14634621</pub-id></mixed-citation></ref><ref id="pone.0007523-Costes1"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costes</surname><given-names>SV</given-names></name><name><surname>Daelemans</surname><given-names>D</given-names></name><name><surname>Cho</surname><given-names>E</given-names></name><name><surname>Dobbin</surname><given-names>Z</given-names></name><name><surname>Pavlakis</surname><given-names>G</given-names></name><etal/></person-group><year>2004</year><article-title>Automatic and quantitative measurement of protein-protein colocalization in live cells.</article-title><source>Biophys J</source><volume>86</volume><fpage>3993</fpage><lpage>4003</lpage><pub-id pub-id-type="pmid">15189895</pub-id></mixed-citation></ref><ref id="pone.0007523-Alessi1"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alessi</surname><given-names>DR</given-names></name><name><surname>Pearce</surname><given-names>LR</given-names></name><name><surname>Garc&#x000ed;a-Mart&#x000ed;nez</surname><given-names>JM</given-names></name></person-group><year>2009</year><article-title>New insights into mTOR signaling: mTORC2 and beyond.</article-title><source>Sci Signal</source><volume>2</volume><fpage>pe27</fpage><pub-id pub-id-type="pmid">19383978</pub-id></mixed-citation></ref><ref id="pone.0007523-Kwon1"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>SR</given-names></name><name><surname>Yang</surname><given-names>KS</given-names></name><name><surname>Ahn</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>YJ</given-names></name><etal/></person-group><year>2004</year><article-title>Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors.</article-title><source>Proc Natl Acad Sci U S A</source><volume>101</volume><fpage>16419</fpage><lpage>16424</lpage><pub-id pub-id-type="pmid">15534200</pub-id></mixed-citation></ref><ref id="pone.0007523-Ohori1"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohori</surname><given-names>K</given-names></name><name><surname>Miura</surname><given-names>T</given-names></name><name><surname>Tanno</surname><given-names>M</given-names></name><name><surname>Miki</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><etal/></person-group><year>2008</year><article-title>Ser9-phosphorylation of mitochondrial GSK-3{beta} is a primary mechanism of cardiomyocyte protection by erythropoietin against oxidant-induced apoptosis.</article-title><source>Am J Physiol Heart Circ Physiol</source><volume>295</volume><fpage>H2079</fpage><lpage>2086</lpage><pub-id pub-id-type="pmid">18805899</pub-id></mixed-citation></ref><ref id="pone.0007523-Wang1"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Peng</surname><given-names>X</given-names></name><name><surname>Perpetua</surname><given-names>M</given-names></name><name><surname>Harbrecht</surname><given-names>BG</given-names></name></person-group><year>2008</year><article-title>Bcl-x<sub>L</sub> prevents staurosporine-induced hepatocyte apoptosis by restoring protein kinase B/mitogen-activated protein kinase activity and mitochondria integrity.</article-title><source>J Cell Physiol</source><volume>215</volume><fpage>676</fpage><lpage>683</lpage><pub-id pub-id-type="pmid">18163394</pub-id></mixed-citation></ref><ref id="pone.0007523-Liu1"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Powlas</surname><given-names>J</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Oleksijew</surname><given-names>AX</given-names></name><name><surname>Shoemaker</surname><given-names>AR</given-names></name><etal/></person-group><year>2004</year><article-title>Rapamycin inhibits Akt-mediated oncogenic transformation and tumor growth.</article-title><source>Anticancer Res</source><volume>24</volume><fpage>2697</fpage><lpage>2704</lpage><pub-id pub-id-type="pmid">15517874</pub-id></mixed-citation></ref><ref id="pone.0007523-Toker1"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toker</surname><given-names>A</given-names></name><name><surname>Newton</surname><given-names>AC</given-names></name></person-group><year>2000</year><article-title>Cellular signaling: pivoting around PDK-1.</article-title><source>Cell</source><volume>103</volume><fpage>185</fpage><lpage>188</lpage><pub-id pub-id-type="pmid">11057891</pub-id></mixed-citation></ref><ref id="pone.0007523-Bayascas1"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bayascas</surname><given-names>JR</given-names></name><name><surname>Wullschleger</surname><given-names>S</given-names></name><name><surname>Sakamoto</surname><given-names>K</given-names></name><name><surname>Garc&#x000ed;a-Mart&#x000ed;nez</surname><given-names>JM</given-names></name><name><surname>Clacher</surname><given-names>C</given-names></name><etal/></person-group><year>2008</year><article-title>Mutation of the PDK1 PH Domain Inhibits Protein Kinase B/Akt, Leading to Small Size and Insulin Resistance.</article-title><source>Mol Cell Biol</source><volume>28</volume><fpage>3258</fpage><lpage>3272</lpage><pub-id pub-id-type="pmid">18347057</pub-id></mixed-citation></ref><ref id="pone.0007523-Calleja1"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calleja</surname><given-names>V</given-names></name><name><surname>Alcor</surname><given-names>D</given-names></name><name><surname>Laguerre</surname><given-names>M</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Vojnovic</surname><given-names>B</given-names></name><etal/></person-group><year>2007</year><article-title>Intramolecular and intermolecular interactions of protein kinase B define its activation in vivo.</article-title><source>PLoS Biol</source><volume>4</volume><fpage>e95</fpage><pub-id pub-id-type="pmid">17407381</pub-id></mixed-citation></ref><ref id="pone.0007523-Filippa1"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filippa</surname><given-names>N</given-names></name><name><surname>Sable</surname><given-names>CL</given-names></name><name><surname>Hemmings</surname><given-names>BA</given-names></name><name><surname>Van Obberghen</surname><given-names>E</given-names></name></person-group><year>2000</year><article-title>Effect of phosphoinositide-dependent kinase 1 on protein kinase B translocation and its subsequent activation.</article-title><source>Mol Cell Biol</source><volume>20</volume><fpage>5712</fpage><lpage>5721</lpage><pub-id pub-id-type="pmid">10891507</pub-id></mixed-citation></ref><ref id="pone.0007523-Connor1"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Connor</surname><given-names>KM</given-names></name><name><surname>Subbaram</surname><given-names>S</given-names></name><name><surname>Regan</surname><given-names>KJ</given-names></name><name><surname>Nelson</surname><given-names>KK</given-names></name><name><surname>Mazurkiewicz</surname><given-names>JE</given-names></name><etal/></person-group><year>2005</year><article-title>Mitochondrial H2O2 regulates the angiogenic phenotype via PTEN oxidation.</article-title><source>J Biol Chem</source><volume>280</volume><fpage>16916</fpage><lpage>16924</lpage><pub-id pub-id-type="pmid">15701646</pub-id></mixed-citation></ref><ref id="pone.0007523-Aran1"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aran</surname><given-names>M</given-names></name><name><surname>Caporaletti</surname><given-names>D</given-names></name><name><surname>Senn</surname><given-names>AM</given-names></name><name><surname>Tellez de I&#x000f1;on</surname><given-names>MT</given-names></name><name><surname>Girotti</surname><given-names>M</given-names></name><etal/></person-group><year>2008</year><article-title>ATP-dependent modulation and autophosphorylation of rapeseed 2-Cys peroxiredoxin.</article-title><source>FEBS J</source><volume>275</volume><fpage>1450</fpage><lpage>1463</lpage><pub-id pub-id-type="pmid">18279387</pub-id></mixed-citation></ref><ref id="pone.0007523-ToralBarza1"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toral-Barza</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>WG</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>McDonald</surname><given-names>LA</given-names></name><name><surname>Salaski</surname><given-names>EJ</given-names></name><etal/></person-group><year>2007</year><article-title>Discovery of lactoquinomycin and related pyranonaphthoquinones as potent and allosteric inhibitors of AKT/PKB: mechanistic involvement of AKT catalytic activation loop cysteines.</article-title><source>Mol Cancer Ther</source><volume>6</volume><fpage>3028</fpage><lpage>3038</lpage><pub-id pub-id-type="pmid">17989320</pub-id></mixed-citation></ref><ref id="pone.0007523-Galli2"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galli</surname><given-names>S</given-names></name><name><surname>Antico Arciuch</surname><given-names>VG</given-names></name><name><surname>Poderoso</surname><given-names>C</given-names></name><name><surname>Converso</surname><given-names>DP</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><etal/></person-group><year>2008</year><article-title>Tumor cell phenotype is sustained by selective MAPK oxidation in mitochondria.</article-title><source>PLoS ONE</source><volume>3</volume><fpage>e2379</fpage><pub-id pub-id-type="pmid">18545666</pub-id></mixed-citation></ref><ref id="pone.0007523-Bradford1"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradford</surname><given-names>MM</given-names></name></person-group><year>1976</year><article-title>A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.</article-title><source>Anal Biochem</source><volume>72</volume><fpage>248</fpage><lpage>254</lpage><pub-id pub-id-type="pmid">942051</pub-id></mixed-citation></ref><ref id="pone.0007523-Alonso1"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alonso</surname><given-names>M</given-names></name><name><surname>Melani</surname><given-names>M</given-names></name><name><surname>Converso</surname><given-names>DP</given-names></name><name><surname>Jaitovich</surname><given-names>A</given-names></name><name><surname>Paz</surname><given-names>C</given-names></name><etal/></person-group><year>2004</year><article-title>Mitochondrial extracellular signal-regulated kinases 1/2 (ERK1/2) are modulated during brain development.</article-title><source>J Neurochem</source><volume>89</volume><fpage>248</fpage><lpage>256</lpage><pub-id pub-id-type="pmid">15030409</pub-id></mixed-citation></ref><ref id="pone.0007523-Nicoletti1"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicoletti</surname><given-names>I</given-names></name><name><surname>Migliorati</surname><given-names>G</given-names></name><name><surname>Oagliacci</surname><given-names>MC</given-names></name><name><surname>Grignani</surname><given-names>F</given-names></name><name><surname>Riccardi</surname><given-names>CA</given-names></name></person-group><year>1991</year><article-title>Rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry.</article-title><source>J Immunol Meth</source><volume>139</volume><fpage>271</fpage><lpage>279</lpage></mixed-citation></ref><ref id="pone.0007523-Cefaratti1"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cefaratti</surname><given-names>C</given-names></name><name><surname>Romani</surname><given-names>A</given-names></name><name><surname>Scarpa</surname><given-names>A</given-names></name></person-group><year>2000</year><article-title>Differential localization and operation of distinct Mg(2&#x0002b;) transporters in apical and basolateral sides of rat liver plasma membrane.</article-title><source>J Biol Chem</source><volume>275</volume><fpage>3772</fpage><lpage>3780</lpage><pub-id pub-id-type="pmid">10660526</pub-id></mixed-citation></ref><ref id="pone.0007523-Shevchenko1"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shevchenko</surname><given-names>A</given-names></name><name><surname>Tomas</surname><given-names>H</given-names></name><name><surname>Havlis</surname><given-names>J</given-names></name><name><surname>Olsen</surname><given-names>JV</given-names></name><name><surname>Mann</surname><given-names>M</given-names></name></person-group><year>2006</year><article-title>In-gel digestion for mass spectrometric characterization of proteins and proteomes.</article-title><source>Nat Protocols</source><volume>1</volume><fpage>2856</fpage><lpage>2860</lpage></mixed-citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This work was supported by grants from Fundacion Perez Companc, University of Buenos Aires (UBACyT M058), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) (PIP 5495), Agencia Nacional para la Promocion Cientifica y Tecnologica (Foncyt, PICT 21461and 34785) and NIH grant AG016718 (to EC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article>